FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Boehringer Ingelheim Roxane Spiriva HandiHaler Recall

Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsu…

Boehringer Ingelheim Roxane Inc · Columbus, OH

Risk level
Class III
Reported by FDA
Apr 16, 2014
Recall ID
D-1230-2014
Check your lot numberHow we source this data

Summary

Boehringer Ingelheim Roxane recalled Spiriva HandiHaler starting Mar 27, 2014. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1230-2014 on Apr 16, 2014. Reason: Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell. Status: Terminated.

Why it was recalled

Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.

Product description

Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use With HandiHaler Only, 18 mcg (as tiotropium) per capsule, Rx Only, a) NDC 0597-0075-75, 5 Spiriva capsules per blister card, b) NDC 0597-0075-41, 30 Spiriva capsules per blister card, Manufactured by: Boehringer Ingelheim (BI) Pharma, GmbH & Co. KG, Ingelheim, Germany, Marketed by: Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 USA and Pfizer Inc New York, NY 10017 USA, Made in Germany.

Lot numbers, UPCs & expiration codes

a) 5 count capsule blister card: 303012A, Exp Sep 2014; b) 30 count capsules blister card: 303012B, Exp Sep 2014, 303125A, 303253A, Exp Oct 2014, 303895A, 304282A, Exp Nov 2014, 304510A, Exp Dec 2014

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1230-2014
Classification
Class III
Status
Terminated
Recall initiated
Mar 27, 2014
FDA report date
Apr 16, 2014
Quantity
1,276,710 Blister Cards
Recall type
Voluntary: Firm initiated
Recalling firm
Boehringer Ingelheim Roxane Inc

Original FDA data

Every field from FDA enforcement report D-1230-2014, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
67796
Address
1809 Wilson Rd
Code information
a) 5 count capsule blister card: 303012A, Exp Sep 2014; b) 30 count capsules blister card: 303012B, Exp Sep 2014, 303125A, 303253A, Exp Oct 2014, 303895A, 304282A, Exp Nov 2014, 304510A, Exp Dec 2014
Postal code
43228-9579
Report date
Apr 16, 2014
Product type
Drugs
Recall number
D-1230-2014
Classification
Class III
Recalling firm
Boehringer Ingelheim Roxane Inc
Product quantity
1,276,710 Blister Cards
Termination date
Jan 26, 2015
Reason for recall
Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use With HandiHaler Only, 18 mcg (as tiotropium) per capsule, Rx Only, a) NDC 0597-0075-75, 5 Spiriva capsules per blister card, b) NDC 0597-0075-41, 30 Spiriva capsules per blister card, Manufactured by: Boehringer Ingelheim (BI) Pharma, GmbH & Co. KG, Ingelheim, Germany, Marketed by: Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877 USA and Pfizer Inc New York, NY 10017 USA, Made in Germany.
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Mar 27, 2014
Initial firm notification
Letter
Center classification date
Apr 10, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1230-2014, published Apr 16, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls